Following the opening of its West Africa office in Ghana earlier this week, Johnson & Johnson has announced the further expansion of its operations in Africa with the launch of a new office in Nairobi, Kenya. The company’s new presence will bring together multiple teams representing Johnson & Johnson consumer, medical device, pharmaceutical, global public health (GPH) and global community impact (GCI) organizations to deliver an integrated approach to improving health outcomes in the region.
Johnson & Johnson’s office in Kenya will help coordinate the company’s global public health capabilities and resources to deliver sustainable, measurable impact against significant public health needs in the region.
“The opening of the new Johnson & Johnson office will play a major role in supporting our goal of helping to improve the quality of and access to healthcare in the region, while showcasing a model that can be replicated across Africa,” said Vittorio Sereni, Country Manager of the Johnson & Johnson office in Nairobi. “We are building a talented team that will lead the expansion of our product portfolio and continue to provide responsive, comprehensive care solutions to meet the evolving health issues that impact patients and health care providers here. Specifically, our team will prioritize issues that matter most to Kenya including multidrug-resistant tuberculosis (MDR TB) and the increasing burden of chronic disease, as well as continuing our focus on HIV and maternal, child and newborn health.”
Related;
Boeing opens offices in Joburg & Nairobi to meet increasing air traffic demand
Afreximbank says its closing in on setting up regional HQ in Nairobi
Johnson & Johnson’s presence in Africa includes business operations, public health programs and corporate citizenship. The operations expand upon the company’s legacy and presence in Africa, which began in 1930, and build on existing work conducted by the more than 1,500 employees and the three manufacturing sites on the continent.
